Abstract
IntroductionImmunomodulator agents are commonly employed in the management of inflammatory bowel disease (IBD). These can increase the risk for opportunistic infections. This study aims to assess patient awareness for the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have